×
For best experience we recommend to activate Javascript in your browser.
CD25 antibody (FITC)
IL2RA
Reactivity: Rat
FACS
Host: Mouse
Monoclonal
OX-39
FITC
Product Details anti-CD25 Antibody (FITC)
(hide)
Target
See all CD25 (IL2RA) Antibodies
CD25 (IL2RA)
(Interleukin 2 Receptor, alpha (IL2RA))
Reactivity
All reactivities for CD25 antibodies
Rat
Host
All hosts for CD25 antibodies
Mouse
Clonality
All clonalities for CD25 antibodies
Monoclonal
Conjugate
All conjugates for CD25 antibodies
This CD25 antibody is conjugated to FITC
Application
All applications for CD25 antibodies
Flow Cytometry (FACS)
Purification
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions. The solution is free of unconjugated FITC.
Clone
OX-39
Isotype
IgG1 kappa
Top Product
Discover our top product IL2RA Primary Antibody
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Concentration
0.5 mg/mL
Buffer
Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.5 % BSA .
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Protect from prolonged exposure to light. Do not freeze.
Storage
4 °C
Storage Comment
The antibody solution should be stored undiluted between 2°C and 8°C.
Target Details for CD25
(hide)
Target
CD25 (IL2RA)
(Interleukin 2 Receptor, alpha (IL2RA))
Alternative Name
CD25 (IL2RA Products )
Background
CD25 is a 55 kD glycoprotein also known as IL-2 receptor α chain. It is broadly expressed on activated T and B cells, a subset of thymic and splenic dendritic cells, and intestinal epithelial cells in the rat. IL-2 is a critical cytokine involved in lymphocyte proliferation and clonal expansion. IL-2 signaling requires the high affinity IL-2 receptor composed of IL-2 receptor chains α, β, and γ. The OX-39 antibody weakly inhibits IL-2 binding to the IL-2 receptor and has been shown to block some IL-2 mediated responses in vitro.
Pathways
JAK-STAT Signaling , Growth Factor Binding , Activated T Cell Proliferation
Recently viewed
(hide)